Home Cart 0 Sign in  
X

[ CAS No. 1159511-89-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 1159511-89-3
Chemical Structure| 1159511-89-3
Chemical Structure| 1159511-89-3
Structure of 1159511-89-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1159511-89-3 ]

Related Doc. of [ 1159511-89-3 ]

Alternatived Products of [ 1159511-89-3 ]

Product Details of [ 1159511-89-3 ]

CAS No. :1159511-89-3 MDL No. :MFCD12028635
Formula : C9H9BrN2 Boiling Point : -
Linear Structure Formula :- InChI Key :CJUCAYMTGYRYEH-UHFFFAOYSA-N
M.W : 225.09 Pubchem ID :44119467
Synonyms :

Calculated chemistry of [ 1159511-89-3 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.22
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 53.66
TPSA : 17.82 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.81 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.29
Log Po/w (XLOGP3) : 2.63
Log Po/w (WLOGP) : 2.64
Log Po/w (MLOGP) : 2.49
Log Po/w (SILICOS-IT) : 2.54
Consensus Log Po/w : 2.52

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.45
Solubility : 0.0803 mg/ml ; 0.000357 mol/l
Class : Soluble
Log S (Ali) : -2.65
Solubility : 0.499 mg/ml ; 0.00222 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.72
Solubility : 0.0429 mg/ml ; 0.000191 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.63

Safety of [ 1159511-89-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1159511-89-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1159511-89-3 ]

[ 1159511-89-3 ] Synthesis Path-Downstream   1~8

YieldReaction ConditionsOperation in experiment
In ethyl acetate at 20℃; for 14.5h; Preparation 33: 5-Bromo-4-fluoro-2-methyl-2H-indazole General procedure: To a suspension of 5-bromo-4-fluoro-1H-indazole (1.0 g, 4.7 mmol) in EtOAc (20 mL) was added trimethyloxonium tetrafluoroborate (1 .0 g, 7.0 mmol) at room temperature. After stirring at the same temperature for 14.5 h, the mixture was quenched with sat. NaHCO3 aq. and extracted with EtOAc. The organic phase was washed with brine, dried over Na2SO4, filtered, and concentrated in vacuo. Theresidue was purified by column chromatography on silica gel (gradient elution, 0-60% EtOAc/hexane) to give the title compound (0.91 g), MS: [M+H] = 230.
  • 2
  • [ 1082041-34-6 ]
  • [ 74-88-4 ]
  • [ 1159511-80-4 ]
  • [ 1159511-89-3 ]
YieldReaction ConditionsOperation in experiment
1: 37.8% 2: 21.3% With sodium hydride In N,N-dimethyl-formamide; mineral oil at 0 - 20℃; for 16h;
  • 3
  • [ 22364-25-6 ]
  • [ 1159511-80-4 ]
  • [ 1159511-89-3 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 2 steps 1.1: potassium acetate; 18-crown-6 ether; tert.-butylnitrite; acetic anhydride / chloroform / 16 h / 75 °C 1.2: 2 h / 50 °C 2.1: sodium hydride / N,N-dimethyl-formamide; mineral oil / 16 h / 0 - 20 °C
  • 4
  • [ 1159511-89-3 ]
  • [ 2845125-54-2 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 2 steps 1: potassium acetate; dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2 / 1,4-dioxane / 1 h / 120 °C / Inert atmosphere; Microwave irradiation 2: potassium carbonate; Brettphos Pd G3 / 1,4-dioxane; water / 100 °C / Sealed tube; Inert atmosphere
Multi-step reaction with 2 steps 1: potassium acetate; dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2 / 1,4-dioxane / 1 h / 120 °C / Inert atmosphere; Microwave irradiation; Sealed tube 2: potassium carbonate; BrettPhos Pd G3 / 1,4-dioxane; water / 100 °C / Sealed tube; Inert atmosphere
  • 5
  • [ 1159511-89-3 ]
  • [ CAS Unavailable ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 2 steps 1: potassium acetate; dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2 / 1,4-dioxane / 1 h / 120 °C / Inert atmosphere; Microwave irradiation 2: potassium carbonate; Brettphos Pd G3 / 1,4-dioxane; water / 2 h / 100 °C / Inert atmosphere
Multi-step reaction with 2 steps 1: potassium acetate; dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2 / 1,4-dioxane / 1 h / 120 °C / Inert atmosphere; Microwave irradiation; Sealed tube 2: potassium carbonate; BrettPhos Pd G3 / 1,4-dioxane; water / 2 h / 100 °C / Inert atmosphere
  • 6
  • [ 1159511-89-3 ]
  • [ 2845125-58-6 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 2 steps 1: potassium acetate; dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2 / 1,4-dioxane / 1 h / 120 °C / Inert atmosphere; Microwave irradiation 2: potassium carbonate; Brettphos Pd G3 / 1,4-dioxane; water / 3 h / 100 °C / Sealed tube; Inert atmosphere
Multi-step reaction with 2 steps 1: potassium acetate; dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2 / 1,4-dioxane / 1 h / 120 °C / Inert atmosphere; Microwave irradiation; Sealed tube 2: potassium carbonate; BrettPhos Pd G3 / 1,4-dioxane; water / 3 h / 100 °C / Sealed tube; Inert atmosphere
  • 7
  • [ 1159511-89-3 ]
  • [ 2845125-25-7 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 3 steps 1: potassium acetate; dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2 / 1,4-dioxane / 1 h / 120 °C / Inert atmosphere; Microwave irradiation 2: potassium carbonate; Brettphos Pd G3 / 1,4-dioxane; water / 3 h / 100 °C / Sealed tube; Inert atmosphere 3: lithium aluminium deuteride / tetrahydrofuran / 0.25 h / 20 °C
Multi-step reaction with 3 steps 1: potassium acetate; dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2 / 1,4-dioxane / 1 h / 120 °C / Inert atmosphere; Microwave irradiation; Sealed tube 2: potassium carbonate; BrettPhos Pd G3 / 1,4-dioxane; water / 3 h / 100 °C / Sealed tube; Inert atmosphere 3: lithium aluminium deuteride / tetrahydrofuran / 15 min / 20 °C
  • 8
  • [ 1159511-89-3 ]
  • [ 73183-34-3 ]
  • [ 1315335-61-5 ]
YieldReaction ConditionsOperation in experiment
34% With dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2; potassium acetate In 1,4-dioxane at 120℃; for 1h; Inert atmosphere; Microwave irradiation; 25 2,4-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-indazole. 5-Bromo-2,4-dimethyl-2H-indazole (2.00 g, 8.89 mmol, 1 eq), potassium acetate (2.61 g, 26.7 mmol, 3 eq), Pd(dppf)Cl2^DCM (727 mg, 0.89 mmol, 0.1 eq) and bis(pinacolato)diboron (3.38 g, 13.3 mmol, 1.5 eq) were combined in a vial, which was sealed and placed under an inert atmosphere. 1,4-Dioxane (30 mL) was then added via syringe, and the resulting reaction mixture was stirred at 120 °C under microwave irradiation for 1 h, after which time the reaction mixture was filtered through a pad of Celite with DCM, and solvents were concentrated. The crude residue was purified by column chromatography (3-80% EtOAc in hexanes) to give the product, which co-elutes with de-brominated indazole by column chromatography (819 mg, 34%). The product may be purified by recrystallizing from EtOH. ES-MS [M+H]+= 273.2.
34% With dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2; potassium acetate In 1,4-dioxane at 120℃; for 1h; Inert atmosphere; Microwave irradiation; 25 2,4-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-indazole. 5-Bromo-2,4-dimethyl-2H-indazole (2.00 g, 8.89 mmol, 1 eq), potassium acetate (2.61 g, 26.7 mmol, 3 eq), Pd(dppf)Cl2^DCM (727 mg, 0.89 mmol, 0.1 eq) and bis(pinacolato)diboron (3.38 g, 13.3 mmol, 1.5 eq) were combined in a vial, which was sealed and placed under an inert atmosphere. 1,4-Dioxane (30 mL) was then added via syringe, and the resulting reaction mixture was stirred at 120 °C under microwave irradiation for 1 h, after which time the reaction mixture was filtered through a pad of Celite with DCM, and solvents were concentrated. The crude residue was purified by column chromatography (3-80% EtOAc in hexanes) to give the product, which co-elutes with de-brominated indazole by column chromatography (819 mg, 34%). The product may be purified by recrystallizing from EtOH. ES-MS [M+H]+= 273.2.
With dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2; potassium acetate In 1,4-dioxane at 120℃; Inert atmosphere; Microwave irradiation; Sealed tube; 25 2,4-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-indazole. 5-Bromo-2,4-dimethyl-2H-indazole (2.00 g, 8.89 mmol, 1 eq), potassium acetate (2.61 g, 26.7 mmol, 3 eq), Pd(dppf)Cl2^DCM (727 mg, 0.89 mmol, 0.1 eq) and bis(pinacolato)diboron (3.38 g, 13.3 mmol, 1.5 eq) were combined in a vial, which was sealed and placed under an inert atmosphere. 1,4-Dioxane (30 mL) was then added via syringe, and the resulting reaction mixture was stirred at 120 °C under microwave irradiation for 1 h, after which time the reaction mixture was filtered through a pad of Celite with DCM, and solvents were concentrated. The crude residue was purified by column chromatography (3-80% EtOAc in hexanes) to give the product, which co-elutes with de-brominated indazole by column chromatography (819 mg, 34%). The product may be purified by recrystallizing from EtOH. ES-MS [M+H]+= 273.2.
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1159511-89-3 ]

Bromides

Chemical Structure| 1146637-10-6

[ 1146637-10-6 ]

5-Bromo-2,7-dimethyl-2H-indazole

Similarity: 0.98

Chemical Structure| 590417-95-1

[ 590417-95-1 ]

6-Bromo-2-methyl-2H-indazole

Similarity: 0.94

Chemical Structure| 1159511-86-0

[ 1159511-86-0 ]

4-Bromo-2,5-dimethyl-2H-indazole

Similarity: 0.88

Chemical Structure| 1191616-45-1

[ 1191616-45-1 ]

4-(4-Bromophenyl)-1-methyl-1H-pyrazole

Similarity: 0.87

Chemical Structure| 590417-93-9

[ 590417-93-9 ]

4-Bromo-2-methyl-2H-indazole

Similarity: 0.87

Related Parent Nucleus of
[ 1159511-89-3 ]

Indazoles

Chemical Structure| 1146637-10-6

[ 1146637-10-6 ]

5-Bromo-2,7-dimethyl-2H-indazole

Similarity: 0.98

Chemical Structure| 590417-95-1

[ 590417-95-1 ]

6-Bromo-2-methyl-2H-indazole

Similarity: 0.94

Chemical Structure| 1159511-86-0

[ 1159511-86-0 ]

4-Bromo-2,5-dimethyl-2H-indazole

Similarity: 0.88

Chemical Structure| 590417-93-9

[ 590417-93-9 ]

4-Bromo-2-methyl-2H-indazole

Similarity: 0.87

Chemical Structure| 701910-14-7

[ 701910-14-7 ]

7-Bromo-2-methyl-2H-indazole

Similarity: 0.80